MDR — Material Events
ASX:MDR · 8 articles in the last 12 months · 100% assessed
Click a band to jump to that tier
Major ≥90
Significant 75–89
Notable 50–74
Routine <50
Not assessed
MedAdvisor Sells ANZ Unit Amid US Market Challenges and $60m LossHigh
MedAdvisor FY25 revenue down 36%, sells ANZ business, focuses on US restructuring
29 Aug 2025
·Annual Financial Results
·Unexpected
·85
MedAdvisor Navigates FY25 Setbacks with ANZ Sale and US Business ReviewHigh
MedAdvisor reports FY25 revenue decline, completes capital raise and ANZ sale, eyes US business sale
31 July 2025
·Quarterly Activities Report and Appendix 4C
·85
MedAdvisor Posts $60M Loss, Sells ANZ Business, and Clears DebtHigh
MedAdvisor posts $60.2M loss for FY25, sells ANZ business, becomes debt-free
29 Aug 2025
·Appendix 4E Preliminary Final Report
·Unexpected
·85
MedAdvisor Taps John Ciccio to Lead Next Growth Phase as CEOMedium
MedAdvisor appoints John Ciccio as new CEO and Managing Director, succeeding Rick Ratliff
7 Nov 2025
·Executive Change Announcement
·80
MedAdvisor’s Revenue Halves Amid U.S. Headwinds, Eyes AI-Driven TurnaroundHigh
MedAdvisor reports 53% revenue drop, sells ANZ business, advances U.S. platform transformation
22 Oct 2025
·Quarterly Activities Report and Appendix 4C
·80
MedAdvisor Sells ANZ Unit, Cuts FY25 Guidance, Eyes US Strategic ReviewMedium
MedAdvisor reports 4Q FY25 revenue decline, sells ANZ business, downgrades FY25 guidance, eyes US strategic review
31 July 2025
·Investor Presentation
·75
MedAdvisor Revenue Halves Amid US Headwinds; Strategic Reset UnderwayMedium
MedAdvisor Q1 FY26 revenue halves amid US challenges; strategic transformation underway
22 Oct 2025
·Investor Presentation
·75
No articles in this tier for the last 12 months.